• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical features of deaths in the novel coronavirus epidemic in China.中国新型冠状病毒疫情死亡患者的临床特征。
Rev Med Virol. 2020 May;30(3):e2103. doi: 10.1002/rmv.2103. Epub 2020 Mar 16.
2
Estimating Risk for Death from Coronavirus Disease, China, January-February 2020.估算 2020 年 1-2 月中国新冠肺炎死亡风险。
Emerg Infect Dis. 2020 Jun;26(6):1251-1256. doi: 10.3201/eid2606.200233. Epub 2020 Jun 17.
3
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].[中国2019新型冠状病毒病(COVID-19)疫情的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
4
Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉 2019 年新型冠状病毒感染患者家族聚集性的临床特征。
Virus Res. 2020 Sep;286:198043. doi: 10.1016/j.virusres.2020.198043. Epub 2020 Jun 2.
5
Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.及时对患者进行管理对降低 2019 年冠状病毒病死亡率的重要性。
J Infect Public Health. 2020 Jun;13(6):890-892. doi: 10.1016/j.jiph.2020.04.015. Epub 2020 May 11.
6
Estimating the instant case fatality rate of COVID-19 in China.估算中国 COVID-19 的即时病死率。
Int J Infect Dis. 2020 Aug;97:1-6. doi: 10.1016/j.ijid.2020.04.055. Epub 2020 Apr 24.
7
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
8
Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China.中国湖北省 COVID-19 流行期间慢性阻塞性肺疾病患者的临床病程和结局。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 23;15:2237-2248. doi: 10.2147/COPD.S265004. eCollection 2020.
9
Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China.中国武汉 102 例 2019 年冠状病毒病患者的临床特征和短期预后。
Clin Infect Dis. 2020 Jul 28;71(15):748-755. doi: 10.1093/cid/ciaa243.
10
Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020.新型冠状病毒肺炎(COVID-19)临床特征的趋势:对2019年12月至2020年2月发表的研究的系统评价和荟萃分析
Respir Investig. 2020 Sep;58(5):409-418. doi: 10.1016/j.resinv.2020.05.005. Epub 2020 Jun 28.

引用本文的文献

1
Clinical characteristics, outcomes and risk factors for mortality in hospitalized diabetes and chronic kidney disease patients after COVID-19 infection following widespread vaccination.广泛接种疫苗后 COVID-19 感染住院糖尿病和慢性肾脏病患者的临床特征、结局和死亡风险因素。
J Endocrinol Invest. 2024 Mar;47(3):619-631. doi: 10.1007/s40618-023-02180-7. Epub 2023 Sep 19.
2
Antibody responses to BNT162b2 SARS-CoV-2 mRNA vaccine among healthcare workers and residents of long-term care facilities: A cohort study in Northern Italy.医护人员和长期护理机构居民对BNT162b2 SARS-CoV-2 mRNA疫苗的抗体反应:意大利北部的一项队列研究。
Health Sci Rep. 2023 Feb 11;6(2):e1087. doi: 10.1002/hsr2.1087. eCollection 2023 Feb.
3
Explanation of COVID-19 Mortality Using Artificial Neural Network Based on Underlying and Laboratory Risk Factors in Ilam, Iran.基于伊朗伊拉姆潜在和实验室风险因素,利用人工神经网络对新冠病毒疾病死亡率的解释
Arch Razi Inst. 2022 Jun 30;77(3):1327-1332. doi: 10.22092/ARI.2021.355438.1684. eCollection 2022 Jun.
4
Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients.新冠后抑郁及其多种因素,法匹拉韦是否具有保护作用?一项对印度尼西亚 COVID-19 患者的纵向研究。
PLoS One. 2022 Dec 30;17(12):e0279184. doi: 10.1371/journal.pone.0279184. eCollection 2022.
5
Cardiopulmonary and hematological effects of infrared LED photobiomodulation in the treatment of SARS-COV2.红外 LED 光生物调节治疗 SARS-COV2 的心肺和血液学效应。
J Photochem Photobiol B. 2023 Jan;238:112619. doi: 10.1016/j.jphotobiol.2022.112619. Epub 2022 Dec 5.
6
The effect of pecha-kucha training on fear and belief in myths of COVID-19 in elderly women.佩查库查训练对老年女性对新冠病毒恐惧及相关谣言认知的影响
Int J Disaster Risk Reduct. 2022 Nov;82:103353. doi: 10.1016/j.ijdrr.2022.103353. Epub 2022 Oct 21.
7
Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?2019冠状病毒病(COVID-19)患者的胃肠道症状——是友还是敌?
Prz Gastroenterol. 2022;17(3):219-226. doi: 10.5114/pg.2021.111000. Epub 2021 Nov 18.
8
Long-term diet and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) severity.长期饮食与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染和 2019 年冠状病毒病(COVID-19)严重程度的关系。
Am J Clin Nutr. 2022 Dec 19;116(6):1672-1681. doi: 10.1093/ajcn/nqac219.
9
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people.与老年人中较低的 SARS-CoV-2 BNT162b2 mRNA 疫苗反应相关的免疫缺陷。
JCI Insight. 2022 Sep 8;7(17):e161045. doi: 10.1172/jci.insight.161045.
10
COVID-19 Risk Prediction for Diabetic Patients Using Fuzzy Inference System and Machine Learning Approaches.使用模糊推理系统和机器学习方法预测糖尿病患者的 COVID-19 风险。
J Healthc Eng. 2022 Apr 1;2022:4096950. doi: 10.1155/2022/4096950. eCollection 2022.

本文引用的文献

1
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
2
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
3
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
4
Cross-species transmission of the newly identified coronavirus 2019-nCoV.新型冠状病毒 2019-nCoV 的跨物种传播。
J Med Virol. 2020 Apr;92(4):433-440. doi: 10.1002/jmv.25682.
5
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.新型冠状病毒持续的2019 - nCoV疫情对全球健康构成威胁——中国武汉最新的2019新型冠状病毒爆发。
Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14.

中国新型冠状病毒疫情死亡患者的临床特征。

Clinical features of deaths in the novel coronavirus epidemic in China.

机构信息

Deakin University, Melbourne, Victoria, Australia.

出版信息

Rev Med Virol. 2020 May;30(3):e2103. doi: 10.1002/rmv.2103. Epub 2020 Mar 16.

DOI:10.1002/rmv.2103
PMID:32175637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228265/
Abstract

In response to the recent novel coronavirus outbreak originating in Wuhan, Hubei province, China, observations concerning novel coronavirus mortality are of urgent public health importance. The present work presents the first review of the fatal novel coronavirus cases in China. Clinical data of fatal cases published by the Chinese Government were studied. As of 2 February 2020, the clinical data of 46 fatal cases were identified. The case fatality rate was significantly higher in Hubei province than the rest of China. While 67% of all deceased patients were male, gender was unlikely to be associated with mortality. Diabetes was likely to be associated with mortality. There is, however, not yet sufficient evidence to support the association between hypertension and mortality as similar prevalence of hypertension was also observed in the Hubei population.

摘要

针对源自中国湖北省武汉市的新型冠状病毒爆发,有关新型冠状病毒死亡率的观察结果对公共卫生具有重要意义。本研究首次对中国的新型冠状病毒致死病例进行了综述。研究了中国政府公布的致死病例的临床数据。截至 2020 年 2 月 2 日,共确定了 46 例致死病例。湖北省的病死率明显高于中国其他地区。虽然所有死亡患者中有 67%为男性,但性别似乎与死亡率无关。糖尿病可能与死亡率有关。但是,尚无足够证据支持高血压与死亡率之间的关联,因为在湖北人群中也观察到了类似的高血压患病率。